Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1991 4
1992 2
1993 1
1994 1
1995 3
1996 2
1997 1
1998 2
1999 1
2001 3
2002 4
2003 8
2004 4
2005 5
2006 8
2007 6
2008 9
2009 3
2010 4
2011 5
2012 6
2013 13
2014 7
2015 15
2016 14
2017 12
2018 17
2019 16
2020 29
2021 37
2022 19
2023 31
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

279 results

Results by year

Filters applied: . Clear all
Page 1
Magrolimab in Combination With Azacitidine in Patients With Higher-Risk Myelodysplastic Syndromes: Final Results of a Phase Ib Study.
Sallman DA, Al Malki MM, Asch AS, Wang ES, Jurcic JG, Bradley TJ, Flinn IW, Pollyea DA, Kambhampati S, Tanaka TN, Zeidner JF, Garcia-Manero G, Jeyakumar D, Komrokji R, Lancet J, Kantarjian HM, Gu L, Zhang Y, Tan A, Chao M, O'Hear C, Ramsingh G, Lal I, Vyas P, Daver NG. Sallman DA, et al. Among authors: kambhampati s. J Clin Oncol. 2023 May 20;41(15):2815-2826. doi: 10.1200/JCO.22.01794. Epub 2023 Mar 8. J Clin Oncol. 2023. PMID: 36888930 Free PMC article. Clinical Trial.
Pevonedistat plus azacitidine vs azacitidine alone in higher-risk MDS/chronic myelomonocytic leukemia or low-blast-percentage AML.
Adès L, Girshova L, Doronin VA, Díez-Campelo M, Valcárcel D, Kambhampati S, Viniou NA, Woszczyk D, De Paz Arias R, Symeonidis A, Anagnostopoulos A, Munhoz EC, Platzbecker U, Santini V, Fram RJ, Yuan Y, Friedlander S, Faller DV, Sekeres MA. Adès L, et al. Among authors: kambhampati s. Blood Adv. 2022 Sep 13;6(17):5132-5145. doi: 10.1182/bloodadvances.2022007334. Blood Adv. 2022. PMID: 35728048 Free PMC article. Clinical Trial.
Reviewer's Checklists for Evaluating Scientific Manuscripts.
Vishwanathan K, Kambhampati SBS, Maini L. Vishwanathan K, et al. Among authors: kambhampati sbs. Indian J Orthop. 2022 Jan 25;56(2):175-182. doi: 10.1007/s43465-022-00602-x. eCollection 2022 Feb. Indian J Orthop. 2022. PMID: 35140849 Free PMC article. No abstract available.
Sarcopenia and Osteoporosis.
Das C, Das PP, Kambhampati SBS. Das C, et al. Among authors: kambhampati sbs. Indian J Orthop. 2023 Nov 19;57(Suppl 1):33-41. doi: 10.1007/s43465-023-01022-1. eCollection 2023 Dec. Indian J Orthop. 2023. PMID: 38107805 Review.
Slide-tags enables single-nucleus barcoding for multimodal spatial genomics.
Russell AJC, Weir JA, Nadaf NM, Shabet M, Kumar V, Kambhampati S, Raichur R, Marrero GJ, Liu S, Balderrama KS, Vanderburg CR, Shanmugam V, Tian L, Iorgulescu JB, Yoon CH, Wu CJ, Macosko EZ, Chen F. Russell AJC, et al. Among authors: kambhampati s. Nature. 2024 Jan;625(7993):101-109. doi: 10.1038/s41586-023-06837-4. Epub 2023 Dec 13. Nature. 2024. PMID: 38093010 Free PMC article.
Authorship in Scientific Manuscripts.
Kambhampati SBS, Maini L. Kambhampati SBS, et al. Indian J Orthop. 2023 May 2;57(6):783-788. doi: 10.1007/s43465-023-00896-5. eCollection 2023 Jun. Indian J Orthop. 2023. PMID: 37214360 Free PMC article. Review.
Immune Checkpoint Inhibitors for Child-Pugh Class B Advanced Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.
Xie E, Yeo YH, Scheiner B, Zhang Y, Hiraoka A, Tantai X, Fessas P, de Castro T, D'Alessio A, Fulgenzi CAM, Xu S, Tsai HM, Kambhampati S, Wang W, Keenan BP, Gao X, Xing Z, Pinter M, Lin YJ, Guo Z, Vogel A, Tanaka T, Kuo HY, Kelley RK, Kudo M, Yang JD, Pinato DJ, Ji F. Xie E, et al. Among authors: kambhampati s. JAMA Oncol. 2023 Oct 1;9(10):1423-1431. doi: 10.1001/jamaoncol.2023.3284. JAMA Oncol. 2023. PMID: 37615958 Free PMC article.
Tolerability and Efficacy of the Anticluster of Differentiation 47 Antibody Magrolimab Combined With Azacitidine in Patients With Previously Untreated AML: Phase Ib Results.
Daver NG, Vyas P, Kambhampati S, Al Malki MM, Larson RA, Asch AS, Mannis G, Chai-Ho W, Tanaka TN, Bradley TJ, Jeyakumar D, Wang ES, Sweet K, Kantarjian HM, Garcia-Manero G, Komrokji R, Xing G, Ramsingh G, Renard C, Zeidner JF, Sallman DA. Daver NG, et al. Among authors: kambhampati s. J Clin Oncol. 2023 Nov 1;41(31):4893-4904. doi: 10.1200/JCO.22.02604. Epub 2023 Sep 13. J Clin Oncol. 2023. PMID: 37703506 Free PMC article. Clinical Trial.
Ethics in Research and Publications.
Kambhampati SBS, Menon J, Maini L. Kambhampati SBS, et al. Indian J Orthop. 2023 Aug 28;57(11):1722-1734. doi: 10.1007/s43465-023-00971-x. eCollection 2023 Nov. Indian J Orthop. 2023. PMID: 37881290 Review.
279 results